Telco Voicemail partnershipsNorwood confirms that it is currently developing go-to-market distribution partnerships for World Voicemail with several prospective telco vendors. Norwood previously advised that it anticipated the formalisation of such a partnership in the September 2019 quarter, and whilst an agreement has not yet been achieved Norwood advises that such discussions are continuing afoot and progressing well, an agreement is currently expected (based on discussions-in-progress) in the current March 2020 quarter .
The above extract is where your focus as an investor should be , imo .
The financial situation and however they presented it would be of absolutely no surprise to anyone .
Do you lot honestly believe that the quarterly report and its content was the main reason for two new institutional investors ( 7Sundays & Leon Capital ) to become new top holders , or do you think that the above extract would offer a more feasible reason ? DYOR
Note :
Im not 100% sure if the new Spark agreement effective immediately and the anticipated to continue until date of 30 June 2020 is a typo or not ? I hope it’s a typo !
- Forums
- ASX - By Stock
- NOR
- Ann: Quarterly Activities and Appendix 4C Cashflow Report
Ann: Quarterly Activities and Appendix 4C Cashflow Report, page-11
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.32M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 153264 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.045 |
2 | 55968 | 0.043 |
2 | 162609 | 0.041 |
3 | 450000 | 0.039 |
1 | 255000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 153264 | 2 |
0.047 | 142144 | 2 |
0.048 | 61184 | 1 |
0.050 | 590074 | 5 |
0.056 | 60000 | 1 |
Last trade - 14.00pm 15/07/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online